DMeOB
From Wikipedia, the free encyclopedia
![]() |
|
![]() |
|
Identifiers | |
---|---|
|
|
CAS Number | 40252-74-2 ![]() |
PubChem (CID) | 6891506 |
ChemSpider | 5277863 ![]() |
ECHA InfoCard | 100.164.778 |
Chemical and physical data | |
Formula | C16H16N2O2 |
Molar mass | 268.310 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
![]() ![]() |
DMeOB is a drug used in scientific research which acts as a negative allosteric modulator of the metabotropic glutamate receptor subtype mGluR5.[1]
References[edit]
- ^ O'Brien JA, Lemaire W, Chen TB, Chang RS, Jacobson MA, Ha SN, Lindsley CW, Schaffhauser HJ, Sur C, Pettibone DJ, Conn PJ, Williams DL (September 2003). "A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5". Molecular Pharmacology. 64 (3): 731–40. doi:10.1124/mol.64.3.731. PMID 12920211.
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |